AMENDMENT TO CONVERTIBLE NOTE & STANDSTILL AGREEMENTConvertible Note & Standstill Agreement • December 23rd, 2020 • GT Biopharma, Inc. • Pharmaceutical preparations
This Amendment to Convertible Note & Standstill Agreement (this “Amendment”) is entered into as of December [●], 2020 (the “Effective Date”), by and between GT Biopharma, Inc., a Delaware corporation (the “Borrower”) and [●], a [●] (the “Holder” and together with the Borrower, the “Parties”) with respect to that certain Convertible Note Due December 19, 2020, dated June 19, 2020, in the principal amount of [●] (the “Note”). Any capitalized term used in this Amendment and not otherwise defined shall have the meaning ascribed to it in the Note.
